ARC Desk

Hematology Diagnostics Market 2018 Industry Size, Trends and Growth By 2026 - ARC Analysis

Lehdistötiedote   •   Syys 17, 2019 09:34 EEST

According to the ARC, the global Hematology Diagnostics Market is anticipated to exceed US$ 9.54 Bn by 2026, along with the projected CAGR of 5.8% from 2018 to 2026.

The Hematology Diagnostics Market report provides a holistic view of the industry along with the factors that are driving and restraining the growth of the global Hematology Diagnostics Market. In addition, the report provides a qualitative and quantitative data that helps in understanding of the historic, current and future industry scenario. The report provides the detailed analysis of the segment and the factors driving the growth of the segment.

The report provides the value chain analysis, Porters Five analysis, and cost structure analysis that gives an industry outlook. It also provides overview of manufacturing plant of the major companies that covers the location of the manufacturing unit, R&D capacity and supplier of the raw materials.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/935

Scope of the Hematology Diagnostics Market Report:

The study provides a decisive view of the Hematology Diagnostics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Segmentation:

Market by Product

  • Instrument
    • Analyzers
    • Flow Cytometers
    • Others
  • Consumables
  • Reagents
  • Stains
  • Others

Market by Test Type

  • Blood count
  • Platelet function
  • Hemoglobin
  • Hematocrit

Market by End Use

  • Hospitals
  • Diagnostic Labs
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on “Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026” offers a detailed insights on global hematology diagnostics market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global hematology diagnostics market by product, test type, end-use and major geographic regions. The report also covers basic healthcare development policies.

The global Hematology Diagnostics Market report cover the comprehensive mapping of the industry players that are operating in target market along with the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.

The major players in the Global Hematology Diagnostics Market include:-

Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc.

The report provides the business outlook of the major player with their business overview, product portfolio, revenue by segment and region. It covers a detailed analysis in the key strategies adopted by the players in order to gain a business upfront against other competitors. The report also provides the strategic overview covering the activities of business players such as merger and acquisition, partnerships and agreements that gives an understanding of their current business scenario.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope

1.1.1. Definition of Hematology Diagnostics

1.1.2. Market Segmentation

1.1.3. List of Abbreviations

1.2. Summary

1.2.1. Market Snapshot

1.2.2. Hematology Diagnostics Market By Product

1.2.2.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026)

1.2.2.2. Global Hematology Diagnostics Market Revenue Share By Product in 2017

1.2.2.3. Instrument

1.2.2.4. Consumables

1.2.2.5. Reagents

1.2.2.6. Stains

1.2.2.7. Others

1.2.3. Hematology Diagnostics Market By Test Type

1.2.3.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By Test Type (2015-2026)

1.2.3.2. Blood count

1.2.3.3. Platelet function

1.2.3.4. Hemoglobin

1.2.3.5. Hematocrit

1.2.3.6. Others

1.2.4. Hematology Diagnostics Market By End Users

1.2.4.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By End Users (2015-2026)

1.2.4.2. Hospitals

1.2.4.3. Diagnostic Labs

1.2.4.4. Others

1.2.5. Hematology Diagnostics Market by Geography

1.2.5.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)

1.2.5.2. North America Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.5.3. Europe Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.5.4. Asia-Pacific Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.5.5. Latin America Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)

1.2.5.6. Middle East and Africa (MEA) Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers

2.2. Restraints and Challenges

2.3. Growth Opportunities

2.4. Porter’s Five Forces Analysis

2.4.1. Bargaining Power of Suppliers

2.4.2. Bargaining Power of Buyers

2.4.3. Threat of Substitute

2.4.4. Threat of New Entrants

2.4.5. Degree of Competition

2.5. Value Chain Analysis

2.6. Cost Structure Analysis

2.6.1. Raw Material and Suppliers

2.6.2. Manufacturing Process Analysis

2.7. Regulatory Compliance

2.8. Competitive Landscape, 2017

2.8.1. Player Positioning Analysis

2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Diagnostic Labs Production Date of Global Hematology Diagnostics Major Manufacturers in 2017

3.2. Manufacturing Plants Distribution of Global Hematology Diagnostics Major Manufacturers in 2017

3.3. R&D Status and Technology Source of Global Hematology Diagnostics Major Manufacturers in 2017

3.4. Raw Materials Sources Analysis of Global Hematology Diagnostics Major Manufacturers in 2017

CHAPTER 4. HEMATOLOGY DIAGNOSTICS MARKET BY PRODUCT

4.1. Global Hematology Diagnostics Revenue By Product

4.2. Instrument

4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.3. Consumables

4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.4. Reagents

4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.5. Stains

4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.6. Other

4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. HEMATOLOGY DIAGNOSTICS MARKET BY TEST TYPE

5.1. Global Hematology Diagnostics Revenue By Test Type

5.2. Blood count

5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.3. Platelet function

5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.4. Hemoglobin

5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.5. Hematocrit

5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.6. Others

5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. HEMATOLOGY DIAGNOSTICS MARKET BY END USERS

6.1. Global Hematology Diagnostics Revenue By End Users

6.2. Hospitals

6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

6.3. Diagnostic Labs

6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

6.4. Others

6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

7.1. North America Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

7.2. North America Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

7.3. U.S.

7.3.1. U.S. Hematology Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

7.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

7.4. Canada

7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

7.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

7.5. Mexico

7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

7.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

8.1. Europe Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

8.2. Europe Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

8.3. UK

8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

8.4. Germany

8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

8.5. France

8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

8.6. Spain

8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

8.7. Rest of Europe

8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

8.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

9.1. Asia-Pacific Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

9.2. Asia-Pacific Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

9.3. China

9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

9.4. Japan

9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

9.5. India

9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

9.6. Australia

9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

9.7. South Korea

9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

9.8. Rest of Asia-Pacific

9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

9.8.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

10.1. Latin America Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

10.2. Latin America Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

10.3. Brazil

10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

10.4. Argentina

10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

10.5. Rest of Latin America

10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

10.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

11.1. Middle East Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

11.2. Middle East Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

11.3. Saudi Arabia

11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

11.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

11.4. UAE

11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

11.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

11.5. Rest of Middle East

11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

11.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

12.1. Africa Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

12.2. Africa Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)

12.3. South Africa

12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

12.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

12.4. Egypt

12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

12.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

12.5. Rest of Africa

12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

12.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Abbott Laboratories

13.1.1. Company Snapshot

13.1.2. Overview

13.1.3. Financial Overview

13.1.4. Type Portfolio

13.1.5. Key Developments

13.1.6. Strategies

13.2. Ortho Clinical Diagnostics

13.2.1. Company Snapshot

13.2.2. Overview

13.2.3. Financial Overview

13.2.4. Type Portfolio

13.2.5. Key Developments

13.2.6. Strategies

13.3. Sysmex Corporation

13.3.1. Company Snapshot

13.3.2. Overview

13.3.3. Financial Overview

13.3.4. Type Portfolio

13.3.5. Key Developments

13.3.6. Strategies

13.4. Boule Diagnostics

13.4.1. Company Snapshot

13.4.2. Overview

13.4.3. Financial Overview

13.4.4. Type Portfolio

13.4.5. Key Developments

13.4.6. Strategies

13.5. F. Hoffmann-La Roche Ltd.

13.5.1. Company Snapshot

13.5.2. Overview

13.5.3. Financial Overview

13.5.4. Type Portfolio

13.5.5. Key Developments

13.5.6. Strategies

13.6. Drew Scientific

13.6.1. Company Snapshot

13.6.2. Overview

13.6.3. Financial Overview

13.6.4. Type Portfolio

13.6.5. Key Developments

13.6.6. Strategies

13.7. Bio-Rad Laboratories

13.7.1. Company Snapshot

13.7.2. Overview

13.7.3. Financial Overview

13.7.4. Type Portfolio

13.7.5. Key Developments

13.7.6. Strategies

13.8. EKF Diagnostics

13.8.1. Company Snapshot

13.8.2. Overview

13.8.3. Financial Overview

13.8.4. Type Portfolio

13.8.5. Key Developments

13.8.6. Strategies

13.9. Beckman Coulter, Inc

13.9.1. Company Snapshot

13.9.2. Overview

13.9.3. Financial Overview

13.9.4. Type Portfolio

13.9.5. Key Developments

13.9.6. Strategies

13.10. Others

13.10.1. Company Snapshot

13.10.2. Overview

13.10.3. Financial Overview

13.10.4. Type Portfolio

13.10.5. Key Developments

13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology

14.1.1. Initial Data Search

14.1.2. Secondary Research

14.1.3. Primary Research

14.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/935

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.